Molecular drivers and cells of origin in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine carcinoma
出版年份 2020 全文链接
标题
Molecular drivers and cells of origin in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine carcinoma
作者
关键词
-
出版物
Experimental Hematology & Oncology
Volume 9, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-10-22
DOI
10.1186/s40164-020-00184-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms
- (2020) Kirstine Nielsen et al. BMC CANCER
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future
- (2020) Eric S Christenson et al. LANCET ONCOLOGY
- A phase II trial of everolimus in patients with advanced pancreatic neuroendocrine carcinoma refractory or intolerant to platinum-containing chemotherapy (NECTOR trial)
- (2020) Hiroyuki Okuyama et al. NEUROENDOCRINOLOGY
- Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: A Systematic Review of a Controversial and Underestimated Diagnosis
- (2020) Melissa Frizziero et al. Journal of Clinical Medicine
- Immunotherapy for pancreatic cancer: A 2020 update
- (2020) Dimitrios Schizas et al. CANCER TREATMENT REVIEWS
- Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors
- (2019) Paloma Cejas et al. NATURE MEDICINE
- FOXA2 Is Required for Enhancer Priming during Pancreatic Differentiation
- (2019) Kihyun Lee et al. Cell Reports
- Transformation to small cell lung cancer as a mechanism of resistance to immunotherapy in non-small cell lung cancer
- (2019) Jair Bar et al. LUNG CANCER
- Liver and pancreas: do similar embryonic development and tissue organization lead to similar mechanisms of tumorigenesis?
- (2018) Elsa Ghurburrun et al. GENE EXPRESSION
- Pancreatic neuroendocrine carcinomas reveal a closer relationship to ductal adenocarcinomas than to neuroendocrine tumors G3
- (2018) Björn Konukiewitz et al. HUMAN PATHOLOGY
- Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model
- (2018) Daniel Benten et al. MOLECULAR CANCER RESEARCH
- Characterization of the Neuroendocrine Tumor Immune Microenvironment
- (2018) Annacarolina da Silva et al. PANCREAS
- Profiling the Tumour Immune Microenvironment in Pancreatic Neuroendocrine Neoplasms with Multispectral Imaging Indicates Distinct Subpopulation Characteristics Concordant with WHO 2017 Classification
- (2018) Daigoro Takahashi et al. Scientific Reports
- Gastroenteropancreatic Neuroendocrine Tumors
- (2018) Mauro Cives et al. CA-A CANCER JOURNAL FOR CLINICIANS
- T-Cell–Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028
- (2018) Patrick A. Ott et al. JOURNAL OF CLINICAL ONCOLOGY
- Mechanosignalling via integrins directs fate decisions of pancreatic progenitors
- (2018) Anant Mamidi et al. NATURE
- Genetic and epigenetic drivers of neuroendocrine tumours (NET)
- (2017) Annunziata Di Domenico et al. ENDOCRINE-RELATED CANCER
- Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas
- (2017) Moritz Jesinghaus et al. MODERN PATHOLOGY
- Somatostatin receptor expression related to TP53 and RB1 alterations in pancreatic and extrapancreatic neuroendocrine neoplasms with a Ki67-index above 20%
- (2017) Björn Konukiewitz et al. MODERN PATHOLOGY
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents
- (2017) Marianne Pavel et al. NEUROENDOCRINOLOGY
- Foxa2 and Pdx1 cooperatively regulate postnatal maturation of pancreatic β-cells
- (2017) Aimée Bastidas-Ponce et al. Molecular Metabolism
- Combined test of serum CgA and NSE improved the power of prognosis prediction of NF-pNETs
- (2017) Yang Lv et al. Endocrine Connections
- Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study
- (2016) Namrata Vijayvergia et al. BRITISH JOURNAL OF CANCER
- Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors
- (2016) Aatur D. Singhi et al. CLINICAL CANCER RESEARCH
- Aberrant Menin expression is an early event in pancreatic neuroendocrine tumorigenesis
- (2016) Wenzel M. Hackeng et al. HUMAN PATHOLOGY
- Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study
- (2016) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas
- (2015) L. H. Tang et al. CLINICAL CANCER RESEARCH
- Human pancreas development
- (2015) R. E. Jennings et al. DEVELOPMENT
- Familial Pancreatic Adenocarcinoma
- (2015) Gloria M. Petersen HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Whole genomes redefine the mutational landscape of pancreatic cancer
- (2015) Nicola Waddell et al. NATURE
- GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas
- (2015) Waki Hosoda et al. VIRCHOWS ARCHIV
- Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
- (2015) Agnieszka K. Witkiewicz et al. Nature Communications
- A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics
- (2015) A. Sadanandam et al. Cancer Discovery
- Cancer-Stellate Cell Interactions Perpetuate the Hypoxia-Fibrosis Cycle in Pancreatic Ductal Adenocarcinoma
- (2015) Mert Erkan et al. NEOPLASIA
- Poorly Differentiated Neuroendocrine Carcinomas of the Pancreas
- (2014) Olca Basturk et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Gastroenteropancreatic high-grade neuroendocrine carcinoma
- (2014) Halfdan Sorbye et al. CANCER
- Targeting mTOR dependency in pancreatic cancer
- (2014) Douglas C Morran et al. GUT
- Epidemiology of gastroenteropancreatic neuroendocrine tumours
- (2013) M. Fraenkel et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Development of the Human Pancreas From Foregut to Endocrine Commitment
- (2013) R. E. Jennings et al. DIABETES
- Evolution and dynamics of pancreatic cancer progression
- (2013) S Yachida et al. ONCOGENE
- Identification and Characterization of Poorly Differentiated Invasive Carcinomas in a Mouse Model of Pancreatic Neuroendocrine Tumorigenesis
- (2013) Karen E. Hunter et al. PLoS One
- Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine Tumors
- (2012) Shinichi Yachida et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Attenuation of the Retinoblastoma Pathway in Pancreatic Neuroendocrine Tumors Due to Increased Cdk4/Cdk6
- (2012) L. H. Tang et al. CLINICAL CANCER RESEARCH
- Presence of Somatic Mutations in Most Early-Stage Pancreatic Intraepithelial Neoplasia
- (2012) Mitsuro Kanda et al. GASTROENTEROLOGY
- Suppression of Tumor Invasion and Metastasis by Concurrent Inhibition of c-Met and VEGF Signaling in Pancreatic Neuroendocrine Tumors
- (2012) Barbara Sennino et al. Cancer Discovery
- Choice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade. A marker study of Chromogranin A, Neuron specific enolase, Progastrin-releasing peptide and cytokeratin fragments
- (2011) Catharina M. Korse et al. EUROPEAN JOURNAL OF CANCER
- Cystic precursors to invasive pancreatic cancer
- (2011) Hanno Matthaei et al. Nature Reviews Gastroenterology & Hepatology
- DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
- (2011) Y. Jiao et al. SCIENCE
- Mammalian target of rapamycin expression in poorly differentiated endocrine carcinoma: clinical and therapeutic future challenges
- (2011) Laura Catena et al. Targeted Oncology
- Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies
- (2010) Milind M Javle et al. BMC CANCER
- Production of Functional Glucagon-Secreting -Cells From Human Embryonic Stem Cells
- (2010) A. Rezania et al. DIABETES
- MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases
- (2010) Vincenzo Corbo et al. ENDOCRINE-RELATED CANCER
- Expression of an activated mammalian target of rapamycin (mTOR) in gastroenteropancreatic neuroendocrine tumors
- (2009) Takashi Shida et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Chromogranin-A and N-Terminal Pro-Brain Natriuretic Peptide: An Excellent Pair of Biomarkers for Diagnostics in Patients With Neuroendocrine Tumor
- (2009) Catharina M. Korse et al. JOURNAL OF CLINICAL ONCOLOGY
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now